尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Rosen Howard B, 董事. Officer active across 3 companies, notably Acelrx Pharmaceuticals INC. In total, 8 disclosures have been recorded. History available since 17 June 2021. The latest transaction was filed on 15 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Howard B. Rosen is a Board Member at AcelRx Pharmaceuticals Inc. and Kala Pharmaceuticals, Inc. With a strong background in the pharmaceutical sector, he plays a key role in overseeing the development and innovation strategies of the companies. His expertise in regulation and compliance is essential to ensure that operations meet industry standards.